33.34
Teva Pharmaceutical Industries Ltd Adr (TEVA) 最新ニュース
Enterprise value to revenue forward of Teva Pharmaceutical Industries Limited Sponsored ADR – BX:TEV - TradingView
Price to earnings forward of Teva Pharmaceutical Industries Limited Sponsored ADR – BX:TEV - TradingView
TEVA Forecast — Price Target — Prediction for 2027 - TradingView
TEV Forecast — Price Target — Prediction for 2027 - TradingView
TEVA/N Forecast — Price Target — Prediction for 2027 - TradingView
Enterprise value to revenue forward of Teva Pharmaceutical Industries Limited Sponsored ADR – FWB:TEV - TradingView
Price to earnings forward of Teva Pharmaceutical Industries Limited Sponsored ADR – FWB:TEV - TradingView
Enterprise value to EBITDA forward of Teva Pharmaceutical Industries Limited Sponsored ADR – FWB:TEV - TradingView
Teva Pharmaceutical Industries Ltd Unsponsored Brazilian Depositary Receipt Repr 0.5 ADR - TradingView
Teva Pharmaceutical Industries Limited Sponsored ADR - TradingView
TEVA News | TEVA PHARMACEUTICAL-SP ADR (NYSE:TEVA) - ChartMill
Teva's Shift Beyond Generics Puts Focus on Branded Drug Growth - TradingView
How Teva’s Ecopipam Tourette NDA and AUSTEDO Data Will Impact Teva Pharmaceutical Industries (TEVA) Investors - Sahm
Teva Pharmaceutical Industries (TEVA) Stock Could Be 23.7% Undervalued After Recent Pullback - Sahm
Teva Seeks FDA Nod for Ecopipam in Pediatric Tourette Syndrome - Yahoo Finance
Teva submits new drug application for pediatric Tourette treatment By Investing.com - Investing.com Canada
Teva Releases Q2 2026 Aide Memoire - GlobeNewswire Inc.
FOCUS-US progesterone supplies tighten as menopause treatment demand grows - Sahm
Teva Extends Neuroscience Focus With Emalex Deal And Valuation Upside Potential - Sahm
Teva Closes Acquisition of Emalex Biosciences, Strengthening Late-Stage Neuroscience Pipeline and Advancing Pivot to Growth Strategy - Sahm
symbol__ Stock Quote Price and Forecast - CNN
ALVO Stock Gains 19% on FDA Resubmission of Biosimilar BLAs - TradingView
How Investors May Respond To Teva (TEVA) Pivoting From Generics Toward Higher-Margin Branded Therapies - Sahm
TEVA Stock Price, Quote & Chart | TEVA PHARMACEUTICAL-SP ADR (NYSE:TEVA) - ChartMill
Teva stock hits 52-week high at $32.02 By Investing.com - Investing.com Nigeria
Assessing Teva (NYSE:TEVA) Valuation After New IMPACT-TD Registry Findings On Tardive Dyskinesia - Sahm
TEVA PHARMACEUTICAL-SP ADR (NYSE:TEVA) Flags Technical Breakout Setup with Top Ratings - ChartMill
Teva- Pharmaceutical Industries Ltd.ADR (TEVA) News, Articles, Events & Latest Updates - Stocktwits
Updating Moat and Valuation for Teva to Reflect Improved Outlook - Morningstar
Teva: Upgrading Moat and Raising Valuation on Portfolio Improvements and Deep Pipeline - Morningstar
TEVATeva- Pharmaceutical Industries Ltd ADR Stock Price and Quote - Finviz
Here's How Much $100 Invested In Teva Pharmaceutical Indus 5 Years Ago Would Be Worth Today - Sahm
A Look At Teva (NYSE:TEVA) Valuation After EMA Accepts Filing For Monthly Schizophrenia Injection - Sahm
Teva Pharmaceutical Industries Limited Sponsored ADR Trade Ideas — LSX:883035 - TradingView
Will Teva’s New TD Data on Young Adults Shift Its Neuroscience-Focused Investment Narrative (TEVA)? - Sahm
Teva Pharmaceutical’s SWOT analysis: stock navigates growth reset - Investing.com
Teva Shares Rise Following Launch of First Generic GLP-1 Weight Loss Drug - MSN
TEVA Stock Chart | TEVA PHARMACEUTICAL-SP ADR (NYSE:TEVA) - ChartMill
A Look At Teva Pharmaceutical Industries (NYSE:TEVA) Valuation After A Strong Year And Recent Pullback - Sahm
Earnings call transcript: Teva Q1 2026 earnings beat forecasts - Investing.com
Earnings call transcript: Teva Q1 2026 earnings beat forecasts By Investing.com - Investing.com Canada
How Investors May Respond To Teva (TEVA) Showcasing CNS Growth And Emalex Deal At Key Conferences - Sahm
Earnings call transcript: Teva beats Q1 2026 expectations with strong growth - Investing.com
Earnings call transcript: Teva beats Q1 2026 expectations with strong growth By Investing.com - Investing.com Australia
Apple Upgraded, American Express Downgraded: Updated Rankings on Top Blue-Chip Stocks - InvestorPlace
TEVA Stock Price Prediction 2025-2026 | Teva Pharma Industries Ltd ADR Forecast - 24/7 Wall St.
A Look At Teva Pharmaceutical Industries (NYSE:TEVA) Valuation After Strong Q1 2026 And Biopharma Pipeline Progress - Sahm
Is It Too Late To Reassess Teva Pharmaceutical Industries (TEVA) After Its Strong Multi Year Rally? - Sahm
Reddit Upgraded, Spotify Downgraded: Updated Rankings on Top Blue-Chip Stocks - InvestorPlace
大文字化:
|
ボリューム (24 時間):